Trials / Unknown
UnknownNCT02749734
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Southwest Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine the safety and therapeutic effect of sub-retinal transplantation of human embryo stem cell derived retinal pigment epitheliums (hESC-RPE) in patients with macular degeneration diseases, and explore new treatment modalities for macular degeneration diseases (Age-related macular degeneration and Stargardt's macular dystrophy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Subretinal transplantation | Transplant hESC-RPE into subretinal space of patients with macular degeneration |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-01
- First posted
- 2016-04-25
- Last updated
- 2018-01-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02749734. Inclusion in this directory is not an endorsement.